These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

519 related articles for article (PubMed ID: 15497198)

  • 21. External Validation of Health Economic Decision Models for Chronic Obstructive Pulmonary Disease (COPD): Report of the Third COPD Modeling Meeting.
    Hoogendoorn M; Feenstra TL; Asukai Y; Briggs AH; Hansen RN; Leidl R; Risebrough N; Samyshkin Y; Wacker M; Rutten-van Mölken MP
    Value Health; 2017 Mar; 20(3):397-403. PubMed ID: 28292484
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A systematic review and economic evaluation of the clinical effectiveness and cost-effectiveness of aldosterone antagonists for postmyocardial infarction heart failure.
    McKenna C; Burch J; Suekarran S; Walker S; Bakhai A; Witte K; Harden M; Wright K; Woolacott N; Lorgelly P; Fenwick L; Palmer S
    Health Technol Assess; 2010 May; 14(24):1-162. PubMed ID: 20492762
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A randomised controlled trial to assess the cost-effectiveness of intensive versus no scheduled follow-up in patients who have undergone resection for colorectal cancer with curative intent.
    Mant D; Gray A; Pugh S; Campbell H; George S; Fuller A; Shinkins B; Corkhill A; Mellor J; Dixon E; Little L; Perera-Salazar R; Primrose J
    Health Technol Assess; 2017 May; 21(32):1-86. PubMed ID: 28641703
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
    Griebsch I; Coast J; Brown J
    Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost-effectiveness of an internet-based perioperative care programme to enhance postoperative recovery in gynaecological patients: economic evaluation alongside a stepped-wedge cluster-randomised trial.
    Bouwsma EVA; Bosmans JE; van Dongen JM; Brölmann HAM; Anema JR; Huirne JAF
    BMJ Open; 2018 Jan; 8(1):e017782. PubMed ID: 29358423
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.
    Shepherd J; Jones J; Takeda A; Davidson P; Price A
    Health Technol Assess; 2006 Aug; 10(28):iii-iv, xi-xiv, 1-183. PubMed ID: 16904047
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is the whole larger than the sum of its parts? Impact of missing data imputation in economic evaluation conducted alongside randomized controlled trials.
    Michalowsky B; Hoffmann W; Kennedy K; Xie F
    Eur J Health Econ; 2020 Jul; 21(5):717-728. PubMed ID: 32108274
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Randomised controlled trial evaluating the effectiveness and cost-effectiveness of 'Families for Health', a family-based childhood obesity treatment intervention delivered in a community setting for ages 6 to 11 years.
    Robertson W; Fleming J; Kamal A; Hamborg T; Khan KA; Griffiths F; Stewart-Brown S; Stallard N; Petrou S; Simkiss D; Harrison E; Kim SW; Thorogood M
    Health Technol Assess; 2017 Jan; 21(1):1-180. PubMed ID: 28059054
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost-Effectiveness of Laparoscopic Hysterectomy With Morcellation Compared With Abdominal Hysterectomy for Presumed Myomas.
    Rutstein SE; Siedhoff MT; Geller EJ; Doll KM; Wu JM; Clarke-Pearson DL; Wheeler SB
    J Minim Invasive Gynecol; 2016 Feb; 23(2):223-33. PubMed ID: 26475764
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The West Midlands ActiVe lifestyle and healthy Eating in School children (WAVES) study: a cluster randomised controlled trial testing the clinical effectiveness and cost-effectiveness of a multifaceted obesity prevention intervention programme targeted at children aged 6-7 years.
    Adab P; Barrett T; Bhopal R; Cade JE; Canaway A; Cheng KK; Clarke J; Daley A; Deeks J; Duda J; Ekelund U; Frew E; Gill P; Griffin T; Hemming K; Hurley K; Lancashire ER; Martin J; McGee E; Pallan MJ; Parry J; Passmore S
    Health Technol Assess; 2018 Feb; 22(8):1-608. PubMed ID: 29436364
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CollAborative care and active surveillance for Screen-Positive EldeRs with subthreshold depression (CASPER): a multicentred randomised controlled trial of clinical effectiveness and cost-effectiveness.
    Lewis H; Adamson J; Atherton K; Bailey D; Birtwistle J; Bosanquet K; Clare E; Delgadillo J; Ekers D; Foster D; Gabe R; Gascoyne S; Haley L; Hargate R; Hewitt C; Holmes J; Keding A; Lilley-Kelly A; Maya J; McMillan D; Meer S; Meredith J; Mitchell N; Nutbrown S; Overend K; Pasterfield M; Richards D; Spilsbury K; Torgerson D; Traviss-Turner G; Trépel D; Woodhouse R; Ziegler F; Gilbody S
    Health Technol Assess; 2017 Feb; 21(8):1-196. PubMed ID: 28248154
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Using QALYs versus DALYs to measure cost-effectiveness: How much does it matter?
    Feng X; Kim DD; Cohen JT; Neumann PJ; Ollendorf DA
    Int J Technol Assess Health Care; 2020 Apr; 36(2):96-103. PubMed ID: 32340631
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost effectiveness of pregabalin in the treatment of fibromyalgia from a UK perspective.
    Choy E; Richards S; Bowrin K; Watson P; Lloyd A; Sadosky A; Zlateva G
    Curr Med Res Opin; 2010 Apr; 26(4):965-75. PubMed ID: 20178405
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Not all "quality-adjusted life years" are equal.
    Marra CA; Marion SA; Guh DP; Najafzadeh M; Wolfe F; Esdaile JM; Clarke AE; Gignac MA; Anis AH
    J Clin Epidemiol; 2007 Jun; 60(6):616-24. PubMed ID: 17493521
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Choice of statistical model for cost-effectiveness analysis and covariate adjustment: empirical application of prominent models and assessment of their results.
    Mantopoulos T; Mitchell PM; Welton NJ; McManus R; Andronis L
    Eur J Health Econ; 2016 Nov; 17(8):927-938. PubMed ID: 26445961
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A forensic evaluation of the National Emphysema Treatment Trial using the expected value of information approach.
    Ramsey SD; Blough DK; Sullivan SD
    Med Care; 2008 May; 46(5):542-8. PubMed ID: 18438203
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical effectiveness and cost-effectiveness of drotrecogin alfa (activated) (Xigris) for the treatment of severe sepsis in adults: a systematic review and economic evaluation.
    Green C; Dinnes J; Takeda A; Shepherd J; Hartwell D; Cave C; Payne E; Cuthbertson BH
    Health Technol Assess; 2005 Mar; 9(11):1-126, iii-iv. PubMed ID: 15774234
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessing the Impact of EQ-5D Country-specific Value Sets on Cost-utility Outcomes.
    van Dongen JM; Jornada Ben Â; Finch AP; Rossenaar MMM; Biesheuvel-Leliefeld KEM; Apeldoorn AT; Ostelo RWJG; van Tulder MW; van Marwijk HWJ; Bosmans JE
    Med Care; 2021 Jan; 59(1):82-90. PubMed ID: 33201085
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Cost-Effectiveness of an Internet Intervention to Facilitate Mental Health Help-Seeking by Young Adults: Randomized Controlled Trial.
    Le LK; Sanci L; Chatterton ML; Kauer S; Buhagiar K; Mihalopoulos C
    J Med Internet Res; 2019 Jul; 21(7):e13065. PubMed ID: 31333199
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost-effectiveness of insulin pumps compared with multiple daily injections both provided with structured education for adults with type 1 diabetes: a health economic analysis of the Relative Effectiveness of Pumps over Structured Education (REPOSE) randomised controlled trial.
    Pollard DJ; Brennan A; Dixon S; Waugh N; Elliott J; Heller S; Lee E; Campbell M; Basarir H; White D;
    BMJ Open; 2018 Apr; 8(4):e016766. PubMed ID: 29627802
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.